Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:15 pm Sale | 2024-12-31 | 13G | Wave Life Sciences Ltd. WVE | MAVERICK CAPITAL LTD | 8,261,242 5.400% | -186,562 (-2.21%) | Filing History |
| 2025-02-05 5:28 pm Purchase | 2024-12-31 | 13G | Wave Life Sciences Ltd. WVE | BlackRock Inc. BLK | 9,360,163 6.100% | 9,360,163 (New Position) | Filing History |
| 2024-11-12 4:30 pm Sale | 2024-09-30 | 13G | Wave Life Sciences Ltd. WVE | M28 Capital Management LP | 6,164,548 4.200% | -1,208,865 (-16.39%) | Filing History |
| 2024-11-12 09:34 am Purchase | 2024-09-30 | 13G | Wave Life Sciences Ltd. WVE | Adage Capital Management L.P. | 9,703,351 6.660% | 9,703,351 (New Position) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Wave Life Sciences Ltd. WVE | BlackRock Inc. BLK | 7,298,423 5.000% | 0 (Unchanged) | Filing |
| 2024-10-18 3:31 pm Purchase | 2024-09-30 | 13G | Wave Life Sciences Ltd. WVE | BlackRock Inc. BLK | 7,298,423 5.000% | 4,434,803 (+154.87%) | Filing |
| 2024-10-01 5:47 pm Purchase | 2024-09-27 | 13D | Wave Life Sciences Ltd. WVE | RA CAPITAL MANAGEMENT LLC | 25,414,165 16.000% | 8,144,354 (+47.16%) | Filing History |
| 2024-02-14 5:02 pm Purchase | 2023-12-31 | 13G | Wave Life Sciences Ltd. WVE | MAVERICK CAPITAL LTD | 8,447,804 6.900% | 1,350,140 (+19.02%) | Filing History |
| 2024-02-14 4:02 pm Sale | 2023-12-31 | 13G | Wave Life Sciences Ltd. WVE | 683 Capital Management LLC | 5,600,000 4.700% | -400,000 (-6.67%) | Filing History |
| 2024-02-13 10:13 am Unchanged | 2023-12-31 | 13G | Wave Life Sciences Ltd. WVE | BB BIOTECH AG | 4,494,458 3.700% | 0 (Unchanged) | Filing History |
| 2024-02-12 4:15 pm Purchase | 2023-12-31 | 13G | Wave Life Sciences Ltd. WVE | M28 Capital Management LP | 7,373,413 6.000% | 1,470,008 (+24.90%) | Filing History |
| 2024-02-07 08:03 am Purchase | 2023-12-31 | 13G | Wave Life Sciences Ltd. WVE | ADAGE CAPITAL PARTNERS GP L.L.C. | 5,987,730 5.030% | 460,846 (+8.34%) | Filing History |
| 2024-02-06 5:07 pm Purchase | 2023-12-31 | 13G | Wave Life Sciences Ltd. WVE | GSK plc | 13,983,761 11.500% | 3,300,000 (+30.89%) | Filing History |
| 2023-02-14 4:08 pm Sale | 2022-12-31 | 13G | Wave Life Sciences Ltd. WVE | BB BIOTECH AG | 4,494,458 5.200% | -108,400 (-2.36%) | Filing History |
| 2023-02-14 2:15 pm Purchase | 2022-12-31 | 13G | Wave Life Sciences Ltd. WVE | 683 Capital Management LLC | 6,000,000 6.900% | 2,369,575 (+65.27%) | Filing History |
| 2023-02-14 11:53 am Purchase | 2022-12-31 | 13G | Wave Life Sciences Ltd. WVE | MAVERICK CAPITAL LTD | 7,097,664 8.200% | 1,504,275 (+26.89%) | Filing History |
| 2023-02-10 4:05 pm Purchase | 2022-12-31 | 13G | Wave Life Sciences Ltd. WVE | M28 Capital Management LP | 5,903,405 6.800% | 2,137,817 (+56.77%) | Filing History |
| 2023-01-30 4:37 pm Purchase | 2023-01-23 | 13G | Wave Life Sciences Ltd. WVE | GSK plc | 10,683,761 10.950% | 10,683,761 (New Position) | Filing History |
| 2022-12-22 4:30 pm Purchase | 2022-12-12 | 13G | Wave Life Sciences Ltd. WVE | ADAGE CAPITAL PARTNERS GP L.L.C. | 5,526,884 6.360% | 5,526,884 (New Position) | Filing History |
| 2022-12-08 11:50 am Sale | 2022-11-30 | 13G | Wave Life Sciences Ltd. WVE | PRIMECAP MANAGEMENT CO | 4,225,908 4.860% | -368,667 (-8.02%) | Filing History |